Moderna Stock Is Top Performer in S&P 500 Tuesday After Miserable 2023. Why This Year Could Be Better.
Share
Moderna stock was one of the worst performers in the S&P 500 last year as Covid-19 vaccine sales tumbled, but the vaccine maker has more to offer, according to Oppenheimer analysts.
Continue reading this article with a Barron’s subscription.
Stock market today: Stocks notch worst weekly decline since March 2023 after August jobs report
Dollar Is Under Pressure Before Key US Jobs Data: Markets Wrap
Morning Bid: Markets hit tentative pause on selloff
Moderna Stock Is Top Performer in S&P 500 Tuesday After Miserable 2023. Why This Year Could Be Better.
Moderna stock was one of the worst performers in the S&P 500 last year as Covid-19 vaccine sales tumbled, but the vaccine maker has more to offer, according to Oppenheimer analysts.
Continue reading this article with a Barron’s subscription.
View Options
Source link
Stock market today: Stocks notch worst weekly decline since March 2023 after August jobs report
Dollar Is Under Pressure Before Key US Jobs Data: Markets Wrap
Morning Bid: Markets hit tentative pause on selloff
Stocks Tumble Most Since August Selloff, Oil Slips: Markets Wrap